Tom Howing In this job you get to meet a lot of remarkable people, none more so than the patients who volunteer to take part in what are giant experiments. They are courageous pioneers, willing to be among the first people to ever try a new therapy, knowing that it may not help them and, … Continue reading Saying thanks and farewell to a friend
Annual Report 2017
A Noble pursuit; finding the best science to help the most people
Mark Noble, Ph.D., is a pioneer in stem cell research and the Director of the University of Rochester Stem Cell and Regenerative Medicine Institute in New York. He is also a member of CIRM’s Grants Working Group (GWG), the panel of independent scientific experts we use to review research applications for funding and decide which … Continue reading A Noble pursuit; finding the best science to help the most people
How a stem cell transplant may help transform Lucas Lindner’s life
On a Sunday morning in early 2016, Lucas Lindner was driving to get some donuts for his grandmother. A deer jumped in front of his truck. Lucas swerved to avoid it and crashed, suffering a severe spinal cord injury that left him paralyzed from the neck down. Lucas took part in a CIRM-funded clinical trial, … Continue reading How a stem cell transplant may help transform Lucas Lindner’s life
Patient’s Stage IV Cancer Held in Check by CIRM-Funded Clinical Trial [Video]
"In the last three scans, which I have every six weeks, they're showing that there is no mestastasis (invasive cancer) anywhere in my body. [The doctors] I guess were quite blown away because they didn't expect [the treatment] to be so quick or to be that complete." Today we’re sharing the story of Tom … Continue reading Patient’s Stage IV Cancer Held in Check by CIRM-Funded Clinical Trial [Video]
A year in review – CIRM’s 2017 Annual Report focuses on a year of accelerating stem cell treatments to patients
At CIRM we have our focus very clearly on the future, on accelerating stem cell therapies to patients with unmet medical needs. But every once in a while, it’s a good idea to look back at what you have already done. Knowing where you came from can help you get to where you are heading. … Continue reading A year in review – CIRM’s 2017 Annual Report focuses on a year of accelerating stem cell treatments to patients
Taking a new approach to fighting a deadly brain cancer
CIRM’s 2017 Annual Report will be going live online very soon. In anticipation of that we are highlighting some of the key elements from the report here on the Stem Cellar. One of the most exciting new approaches in targeting deadly cancers is chimeric antigen receptor (CAR) T-cell therapy, using the patient’s own immune system … Continue reading Taking a new approach to fighting a deadly brain cancer
How CIRM funding creates additional financial support for stem cell research in California
CIRM’s 2017 Annual Report will be going live online very soon. In anticipation of that we are highlighting some of the key elements from the report here on the Stem Cellar. CIRM funds stem cell research. We all know that. What you may not know is that CIRM funds also help bring in additional funding … Continue reading How CIRM funding creates additional financial support for stem cell research in California
How Tom Howing turned to stem cells to battle back against a deadly cancer
As we enter the new year, CIRM’s 2017 Annual Report will be posted in less than two weeks! Here’s one of the people we are profiling in the report, a patient who took part in a CIRM-funded clinical trial. In March of 2015, Tom Howing was diagnosed with stage 4 cancer. Over the next 18 … Continue reading How Tom Howing turned to stem cells to battle back against a deadly cancer
Accelerating stem cell treatments to patients in 2017
As we enter the new year, CIRM’s 2017 Annual Report will be posted in a few short weeks! Here’s a sneak peek at CIRM’s progress in clinical trials. At the start of 2017, we set a goal of finding and funding 12 new, high quality clinical trials. We easily beat that goal, funding 16, in … Continue reading Accelerating stem cell treatments to patients in 2017